Glenn Jaffe, MD, Timothy Murray, MD, MBA
Show Description +
Glenn Jaffe, MD, reviews the limitations of current drug delivery options for various retinal diseases and explains how engineering advances may present new therapeutic options for patients with diseases such as wet AMD and inherited retinal diseases.
Posted: 3/22/2020
Glenn Jaffe, MD, Timothy Murray, MD, MBA
Glenn Jaffe, MD, reviews the limitations of current drug delivery options for various retinal diseases and explains how engineering advances may present new therapeutic options for patients with diseases such as wet AMD and inherited retinal diseases.
Posted: 3/22/2020
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARDS: 2020.
Please log in to leave a comment.